Search Results (20)
Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
The Interplay between Pharmacokinetics and Pharmacodynamics. | Academic Article |
Why?
|
Analysis Approaches to Identify Pharmacogenetic Associations With Pharmacodynamics. | Academic Article |
Why?
|
Assessment of histamine pharmacodynamics by microvasculature response of histamine using histamine iontophoresis laser Doppler flowimetry. | Academic Article |
Why?
|
Developmental pharmacokinetics and pharmacodynamics of nizatidine. | Academic Article |
Why?
|
Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection. | Academic Article |
Why?
|
The integration of pharmacokinetics and pharmacodynamics: understanding dose-response. | Academic Article |
Why?
|
Valproic acid pathway: pharmacokinetics and pharmacodynamics. | Academic Article |
Why?
|
Effect of Obesity on Pantoprazole Pharmacokinetics and Pharmacodynamics in Children | Grant |
Why?
|
An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28?days to <?6?years with chronic kidney disease receiving dialysis. | Academic Article |
Why?
|
Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probe. | Academic Article |
Why?
|
Phase 1, single-dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of etelcalcetide in pediatric patients with secondary hyperparathyroidism receiving hemodialysis. | Academic Article |
Why?
|
Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28?days to <?6?years with chronic kidney disease receiving dialysis. | Academic Article |
Why?
|
Leeder, J. Steven | Person |
Why?
|
Kyler, Kate | Person |
Why?
|
Warady, Bradley | Person |
Why?
|